Are there risks to how GLP-1 medications interact with the brain’s reward system?

That’s one of the key areas scientists are still studying. While current evidence suggests GLP-1s can safely influence reward and impulse control pathways, long-term effects on dopamine signaling and motivation are not yet fully known. Ongoing research aims to better understand these mechanisms and ensure their safety for broader use.